Atherosclerosis Articles

Articles
Exposome in ischaemic heart disease: beyond traditional risk factors
Montone RA, Camilli M, Calvieri C, et al.
Journal:
Eur Heart J

First published: January 18, 2024 DOI: 10.1093/eurheartj/ehae001
View
- Share
Articles
Primary Prevention of Subclinical Atherosclerosis in Young Adults: JACC Review Topic of the Week
Devesa A, Ibanez B, Malick WA, et al.
Journal:
J Am Coll Cardiol

First published: November 28, 2023 DOI: 10.1016/j.jacc.2023.09.817
View
- Share
Articles
Determinants of Progression and Regression of Subclinical Atherosclerosis Over 6 Years
Mendieta G, Pocock S, Mass V, et al.
Journal:
J Am Coll Cardiol

First published: November 28, 2023 DOI: 10.1016/j.jacc.2023.09.814
View
- Share
Articles
The Time to Initiate Anti-Inflammatory Therapy for Patients With Chronic Coronary Atherosclerosis Has Arrived
Ridker PM
Journal:
Circulation

First published: October 2, 2023 DOI: 10.1161/CIRCULATIONAHA.123.066510
View
- Share
Articles
Clinical Pathway for Coronary Atherosclerosis in Patients Without Conventional Modifiable Risk Factors: JACC State-of-the-Art Review
Figtree GA, Vernon ST, Harmer JA, et al.
Journal:
J Am Coll Cardiol

First published: September 26, 2023 DOI: 10.1016/j.jacc.2023.06.045
View
- Share
Articles
2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance
Cuchel M, Raal FJ, Hegele RA, et al.
Journal:
Eur Heart J

First published: May 2, 2023 DOI: 10.1093/eurheartj/ehad197
View
- Share
Articles
Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients with Familial Hypercholesterolemia: The ARCHITECT Study
Pérez de Isla L, Díaz-Díaz JL, Romero MJ, et al.
Journal:
Circulation

First published: April 3, 2023 DOI: 10.1161/CIRCULATIONAHA.122.062557
View
- Share
Articles
Subclinical Coronary Atherosclerosis and Risk for Myocardial Infarction in a Danish Cohort: A Prospective Observational Cohort Study
Fuchs A, Kühl JT, Sigvardsen PE, et al.
Journal:
Ann Intern Med

First published: March 23, 2023 DOI: 10.7326/M22-3027
View
- Share
Articles
Role of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate Continues
Sherratt SCR, Libby P, Budoff MJ, et al.
Journal:
Curr Atheroscler Rep

First published: December 29, 2022 DOI: 10.1007/s11883-022-01075-x
View
- Share
Articles
New Trends and Therapies for Familial Hypercholesterolemia
Alnouri F, Santos RD
Journal:
J Clin Med

First published: November 9, 2022 DOI: 10.3390/jcm11226638
View
- Share
Articles
Lipoprotein(a) levels in a global population with established atherosclerotic cardiovascular disease
Nissen SE, Wolski K, Cho L, et al.
Journal:
Open Heart

First published: October 17, 2022 DOI: 10.1136/openhrt-2022-002060
View
- Share
Articles
EPA Versus Mixed EPA/DHA Plus Statin for Coronary Atherosclerosis: Meta-Analysis of Prospective Imaging Trials
Sheppard JP, Lakshmanan S, Dahal S, et al.
Journal:
JACC Cardiovasc Imaging

First published: October 15, 2022 DOI: 10.1016/j.jcmg.2022.04.014
View
- Share

1 2

Atherosclerosis Articles

Articles

Exposome in ischaemic heart disease: beyond traditional risk factors

Montone RA, Camilli M, Calvieri C, et al.

Articles

Primary Prevention of Subclinical Atherosclerosis in Young Adults: JACC Review Topic of the Week

Devesa A, Ibanez B, Malick WA, et al.

Articles

Determinants of Progression and Regression of Subclinical Atherosclerosis Over 6 Years

Mendieta G, Pocock S, Mass V, et al.

Articles

The Time to Initiate Anti-Inflammatory Therapy for Patients With Chronic Coronary Atherosclerosis Has Arrived

Ridker PM

Articles

Clinical Pathway for Coronary Atherosclerosis in Patients Without Conventional Modifiable Risk Factors: JACC State-of-the-Art Review

Figtree GA, Vernon ST, Harmer JA, et al.

Articles

2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance

Cuchel M, Raal FJ, Hegele RA, et al.

Articles

Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients with Familial Hypercholesterolemia: The ARCHITECT Study

Pérez de Isla L, Díaz-Díaz JL, Romero MJ, et al.

Articles

Subclinical Coronary Atherosclerosis and Risk for Myocardial Infarction in a Danish Cohort: A Prospective Observational Cohort Study

Fuchs A, Kühl JT, Sigvardsen PE, et al.

Articles

Role of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate Continues

Sherratt SCR, Libby P, Budoff MJ, et al.

Articles

New Trends and Therapies for Familial Hypercholesterolemia

Alnouri F, Santos RD

Articles

Lipoprotein(a) levels in a global population with established atherosclerotic cardiovascular disease

Nissen SE, Wolski K, Cho L, et al.

Articles

EPA Versus Mixed EPA/DHA Plus Statin for Coronary Atherosclerosis: Meta-Analysis of Prospective Imaging Trials

Sheppard JP, Lakshmanan S, Dahal S, et al.

Articles

Exposome in ischaemic heart disease: beyond traditional risk factors

Montone RA, Camilli M, Calvieri C, et al.

Share

Articles

Primary Prevention of Subclinical Atherosclerosis in Young Adults: JACC Review Topic of the Week

Devesa A, Ibanez B, Malick WA, et al.

Share

Articles

Determinants of Progression and Regression of Subclinical Atherosclerosis Over 6 Years

Mendieta G, Pocock S, Mass V, et al.

Share

Articles

The Time to Initiate Anti-Inflammatory Therapy for Patients With Chronic Coronary Atherosclerosis Has Arrived

Ridker PM

Share

Articles

Clinical Pathway for Coronary Atherosclerosis in Patients Without Conventional Modifiable Risk Factors: JACC State-of-the-Art Review

Figtree GA, Vernon ST, Harmer JA, et al.

Share

Articles

2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance

Cuchel M, Raal FJ, Hegele RA, et al.

Share

Articles

Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients with Familial Hypercholesterolemia: The ARCHITECT Study

Pérez de Isla L, Díaz-Díaz JL, Romero MJ, et al.

Share

Articles

Subclinical Coronary Atherosclerosis and Risk for Myocardial Infarction in a Danish Cohort: A Prospective Observational Cohort Study

Fuchs A, Kühl JT, Sigvardsen PE, et al.

Share

Articles

Role of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate Continues

Sherratt SCR, Libby P, Budoff MJ, et al.

Share

Articles

New Trends and Therapies for Familial Hypercholesterolemia

Alnouri F, Santos RD

Share

Articles

Lipoprotein(a) levels in a global population with established atherosclerotic cardiovascular disease

Nissen SE, Wolski K, Cho L, et al.

Share

Articles

EPA Versus Mixed EPA/DHA Plus Statin for Coronary Atherosclerosis: Meta-Analysis of Prospective Imaging Trials

Sheppard JP, Lakshmanan S, Dahal S, et al.

Share